CONTENTS:
- The impacts of potency, warning messages, and price on preferences for Cannabis flower products. Shi Y., Cao Y., Shang C., Pacula R.L., p. 1-10.
- Frequently asked questions about dabbing concentrates in online cannabis community discussion forums. Meacham M.C., Roh S., Chang J.S., Ramo D.E., p. 11-17.
- Trajectories of alcohol use problems based on early adolescent alcohol use: Findings from a 35 year population cohort. Boden J.M., Newton-Howes G., Foulds J., Spittlehouse J., Cook S., p. 18-25.
- Narratives of people who inject drugs on factors contributing to opioid overdose. Chang J.S., Behar E., Coffin P.O., p. 26-32.
- Deconstructing prohibitionist ideology: A sociocognitive approach to understand opinions on UK drug policy and the law. Askew R., Bone M., p. 33-40.
- Recent fentanyl use among people who inject drugs: Results from a rapid assessment in Baltimore, Maryland. Buresh M., Genberg B.L., Astemborski J., Kirk G.D., Mehta S.H., p. 41-46.
- Medical marijuana. What can we learn from the experiences in Canada, Germany and Thailand? Rehm J., Elton-Marshall T., Sornpaisarn B., Manthey J., p. 47-51.
- "Another thing to live for": Supporting HCV treatment and cure among Indigenous people impacted by substance use in Canadian cities. Pearce M.E., Jongbloed K., Demerais L., MacDonald H., Christian W.M., Sharma R., et al., p. 52-61.
- Taking opioids in times of crisis: Institutional oversight, chronic pain and suffering in an integrated healthcare delivery system in the U.S. Gruß I., Firemark A., Mayhew M., McMullen C.K., DeBar L.L., p. 62-68.
- Hepatitis C virus treatment in people who inject drugs (PWID) in Bangladesh. Rahman M., Janjua N.Z., Shafiq T.K.I., Chowdhury E.I., Sarker M.S., Khan S.I., et al., p. 69-75.
- "Everything is not right anymore": Buprenorphine experiences in an era of illicit fentanyl. Silverstein S.M., Daniulaityte R., Martins S.S., Miller S.C., Carlson R.G., p. 76-83.
- Public policy, attitudes and willingness to pay for treatment of substance dependence in Iran. Ahmadian Moghaddam S., Mazyaki A., Razaghi E.M., p. 84-89.
- A policy mapping analysis of goals, target populations, and punitive notions in the U.S. congressional response to the opioid epidemic. Bowen E.A., Irish A., p. 90-97.
- The ever-changing narrative: Supervised injection site policy making in Ontario, Canada. Ziegler B.R., Wray A.J.D., Luginaah I., p. 98-111.
- Do New Zealand communities have greater input to local alcohol policy? Population surveys before and after new legislation. Maclennan B., Kypri K., Connor J., p. 112-115.
- Cannabis and youth protection in Colorado's commercial adult-use market: A qualitative investigation. Subritzky T., Lenton S., Pettigrew S., p. 116-126.
- 'It's too much, I'm getting really tired of it': Overdose response and structural vulnerabilities among harm reduction workers in community settings. Kolla G., Strike C., p. 127-135.
- Prevalence and correlates of amphetamine-type stimulant use among transgender women in Cambodia. Mburu G., Tuot S., Mun P., Chhoun P., Chann N., Yi S., p. 136-143.
- Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA. Bessen S., Metcalf S.A., Saunders E.C., Moore S.K., Meier A., McLeman B., et al., p. 144-151.
- The effect of cannabis laws on opioid use. Flexon J.L., Stolzenberg L., D'Alessio S.J., p. 152-159.
- Adulterants and altruism: A qualitative investigation of "drug checkers" in North America. Palamar J.J., Acosta P., Sutherland R., Shedlin M.G., Barratt M.J., p. 160-169.
- Changes in Australian prescription opioid use following codeine rescheduling: A retrospective study using pharmaceutical benefits data. Middleton M., Nielsen S., p. 170-173.
- Prescription drug monitoring programs operational characteristics and fatal heroin poisoning. Martins S.S., Ponicki W., Smith N., Rivera-Aguirre A., Davis C.S., Fink D.S., et al., p. 174-180.
- Pleasure and HIV biomedical discourse: The structuring of sexual and drug-related risks for gay and bisexual men who Party-n-Play. Souleymanov R., Brennan D.J., Logie C., Allman D., Craig S.L., Halkitis P.N., p. 181-190.
- Cannabis legalization in Canada: What are the potential implications and barriers for people living with HIV? Gagnon M., Guta A., p. 191-192.
- Identifying opportunities for engaging the 'community' in local alcohol decision-making: A literature review and synthesis. McGrath M., Reynolds J., Smolar M., Hare S., Ogden M., Popay J., et al., p. 193-204.
- Ambiguous identities of drugs and people: A scoping review of opioid-related stigma. McCradden M.D., Vasileva D., Orchanian-Cheff A., Buchman D.Z., p. 205-215.
- Supply of codeine combination analgesics from Australian pharmacies in the context of voluntary real-time recording and regulatory change: A simulated patient study. Collins J.C., Hillman J.M., Schneider C.R., Moles R.J., p. 216-222.
- Government monopoly as an instrument for public health and welfare: Lessons for cannabis from experience with alcohol monopolies. Room R., Cisneros Örnberg J., p. 223-228.
- Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama. Sisson M.L., McMahan K.B., Chichester K.R., Galbraith J.W., Cropsey K.L., p. 229-235.
- Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia. Saludes V., Antuori A., Folch C., Gonzalez N., Ibanez N., Majo X., et al., p. 236-245.
- Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants. O'Halloran C., Rice B., White E., Desai M., Dunn D.T., McCormack S., et al., p. 246-254.
- Naloxone distribution, trauma, and supporting community-based overdose responders. Shearer D., Fleming T., Fowler A., Boyd J., McNeil R., p. 255-256.
- Comparing Canadian and United States opioid agonist therapy policies. Priest K.C., Gorfinkel L., Klimas J., Jones A.A., Fairbairn N., McCarty D., p. 257-265.
- E-cigarette use is associated with susceptibility to tobacco use among Australian young adults. Jongenelis M.I., Jardine E., Kameron C., Rudaizky D., Pettigrew S., p. 266-273.
- Evidence that social-economic factors play an important role in drug overdose deaths. Heyman G.M., McVicar N., Brownell H., p. 274-284.
- Reproducibility on science: Challenges and advances in Brazilian alcohol surveys. De Boni R.B., de Vasconcellos M.T.L., Silva P.N., Coutinho C., Mota J., Peixoto J.N.B., et al., p. 285-291.
- Associations with drug use and sexualised drug use among women who have sex with women (WSW) in the UK: Findings from the LGBT Sex and Lifestyles Survey. Hibbert M.P., Porcellato L.A., Brett C.E., Hope V.D., p. 292-298.
- Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs. Lambdin B.H., Bluthenthal R.N., Zibbell J.E., Wenger L., Simpson K., Kral A.H., p. 299-304.